Media coverage about Aceto (NASDAQ:ACET) has been trending somewhat negative on Saturday, Accern reports. The research firm identifies negative and positive media coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Aceto earned a news sentiment score of -0.04 on Accern’s scale. Accern also gave media stories about the company an impact score of 45.6257923706464 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.
ACET has been the subject of a number of recent analyst reports. Canaccord Genuity reaffirmed a “buy” rating and set a $10.00 target price on shares of Aceto in a research report on Monday, February 5th. ValuEngine cut Aceto from a “buy” rating to a “hold” rating in a research report on Sunday, December 31st. Zacks Investment Research raised Aceto from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 9th. Finally, BidaskClub raised Aceto from a “strong sell” rating to a “sell” rating in a research report on Thursday, January 4th.
ACET stock traded down $0.07 on Friday, hitting $7.19. The stock had a trading volume of 254,091 shares, compared to its average volume of 285,578. Aceto has a 12 month low of $6.95 and a 12 month high of $17.10. The company has a quick ratio of 1.38, a current ratio of 2.00 and a debt-to-equity ratio of 0.79. The company has a market capitalization of $223.34, a PE ratio of -44.94, a price-to-earnings-growth ratio of 0.71 and a beta of 1.70.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 23rd. Stockholders of record on Friday, March 9th were given a $0.065 dividend. The ex-dividend date was Thursday, March 8th. This represents a $0.26 annualized dividend and a dividend yield of 3.62%. Aceto’s dividend payout ratio is -162.50%.
Aceto Corporation (Aceto) is engaged in the marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products.
Receive News & Ratings for Aceto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aceto and related companies with MarketBeat.com's FREE daily email newsletter.